• Je něco špatně v tomto záznamu ?

Conformational dynamics and antigenicity in the disordered malaria antigen merozoite surface protein 2

CA. MacRaild, M. Zachrdla, D. Andrew, B. Krishnarjuna, J. Nováček, L. Žídek, V. Sklenář, JS. Richards, JG. Beeson, RF. Anders, RS. Norton,

. 2015 ; 10 (3) : e0119899. [pub] 20150305

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc16010488

Merozoite surface protein 2 (MSP2) of Plasmodium falciparum is an abundant, intrinsically disordered protein that is GPI-anchored to the surface of the invasive blood stage of the malaria parasite. Recombinant MSP2 has been trialled as a component of a malaria vaccine, and is one of several disordered proteins that are candidates for inclusion in vaccines for malaria and other diseases. Nonetheless, little is known about the implications of protein disorder for the development of an effective antibody response. We have therefore undertaken a detailed analysis of the conformational dynamics of the two allelic forms of MSP2 (3D7 and FC27) using NMR spectroscopy. Chemical shifts and NMR relaxation data indicate that conformational and dynamic properties of the N- and C-terminal conserved regions in the two forms of MSP2 are essentially identical, but significant variation exists between and within the central variable regions. We observe a strong relationship between the conformational dynamics and the antigenicity of MSP2, as assessed with antisera to recombinant MSP2. Regions of increased conformational order in MSP2, including those in the conserved regions, are more strongly antigenic, while the most flexible regions are minimally antigenic. This suggests that modifications that increase conformational order may offer a means to tune the antigenicity of MSP2 and other disordered antigens, with implications for vaccine design.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16010488
003      
CZ-PrNML
005      
20160408112348.0
007      
ta
008      
160408s2015 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0119899 $2 doi
024    7_
$a 10.1371/journal.pone.0119899 $2 doi
035    __
$a (PubMed)25742002
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a MacRaild, Christopher A $u Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, 3052, Australia.
245    10
$a Conformational dynamics and antigenicity in the disordered malaria antigen merozoite surface protein 2 / $c CA. MacRaild, M. Zachrdla, D. Andrew, B. Krishnarjuna, J. Nováček, L. Žídek, V. Sklenář, JS. Richards, JG. Beeson, RF. Anders, RS. Norton,
520    9_
$a Merozoite surface protein 2 (MSP2) of Plasmodium falciparum is an abundant, intrinsically disordered protein that is GPI-anchored to the surface of the invasive blood stage of the malaria parasite. Recombinant MSP2 has been trialled as a component of a malaria vaccine, and is one of several disordered proteins that are candidates for inclusion in vaccines for malaria and other diseases. Nonetheless, little is known about the implications of protein disorder for the development of an effective antibody response. We have therefore undertaken a detailed analysis of the conformational dynamics of the two allelic forms of MSP2 (3D7 and FC27) using NMR spectroscopy. Chemical shifts and NMR relaxation data indicate that conformational and dynamic properties of the N- and C-terminal conserved regions in the two forms of MSP2 are essentially identical, but significant variation exists between and within the central variable regions. We observe a strong relationship between the conformational dynamics and the antigenicity of MSP2, as assessed with antisera to recombinant MSP2. Regions of increased conformational order in MSP2, including those in the conserved regions, are more strongly antigenic, while the most flexible regions are minimally antigenic. This suggests that modifications that increase conformational order may offer a means to tune the antigenicity of MSP2 and other disordered antigens, with implications for vaccine design.
650    _2
$a antigeny protozoální $x chemie $x imunologie $7 D000953
650    _2
$a nukleární magnetická rezonance biomolekulární $7 D019906
650    _2
$a Plasmodium falciparum $x imunologie $7 D010963
650    _2
$a konformace proteinů $7 D011487
650    _2
$a protozoální proteiny $x chemie $x imunologie $7 D015800
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Zachrdla, Milan $u NCBR, Faculty of Science, Masaryk University, Kamenice 5, 62500, Brno, Czech Republic; CEITEC, Masaryk University, Kamenice 5, 62500, Brno, Czech Republic.
700    1_
$a Andrew, Dean $u Centre for Biomedical Research, Burnet Institute, Melbourne, Victoria, 3004, Australia. $7 gn_A_00006580
700    1_
$a Krishnarjuna, Bankala $u Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, 3052, Australia.
700    1_
$a Nováček, Jiří $u NCBR, Faculty of Science, Masaryk University, Kamenice 5, 62500, Brno, Czech Republic; CEITEC, Masaryk University, Kamenice 5, 62500, Brno, Czech Republic.
700    1_
$a Žídek, Lukáš $u NCBR, Faculty of Science, Masaryk University, Kamenice 5, 62500, Brno, Czech Republic; CEITEC, Masaryk University, Kamenice 5, 62500, Brno, Czech Republic.
700    1_
$a Sklenář, Vladimír $u NCBR, Faculty of Science, Masaryk University, Kamenice 5, 62500, Brno, Czech Republic; CEITEC, Masaryk University, Kamenice 5, 62500, Brno, Czech Republic.
700    1_
$a Richards, Jack S $u Centre for Biomedical Research, Burnet Institute, Melbourne, Victoria, 3004, Australia.
700    1_
$a Beeson, James G $u Centre for Biomedical Research, Burnet Institute, Melbourne, Victoria, 3004, Australia.
700    1_
$a Anders, Robin F $u Department of Biochemistry, La Trobe University, Victoria, 3086, Australia. $7 gn_A_00006050
700    1_
$a Norton, Raymond S $u Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, 3052, Australia.
773    0_
$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 10, č. 3 (2015), s. e0119899
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25742002 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160408 $b ABA008
991    __
$a 20160408112426 $b ABA008
999    __
$a ok $b bmc $g 1113917 $s 934856
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 10 $c 3 $d e0119899 $e 20150305 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
LZP    __
$a Pubmed-20160408

Najít záznam

Citační ukazatele

Možnosti archivace